Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06785129 · ClinicalTrials.gov registry record
Endometriosis and Migraine
A clinical trial of Migraine and Endometriosis, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT06785129: Recruiting study of Migraine and Endometriosis, sponsored by Washington University School of Medicine.
NCT06785129 is a study of Migraine and Endometriosis that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 120 participants, below the 357-participant average among 102 other Migraine trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06785129, a study of Migraine and Endometriosis, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to determine differences in experimental pain and sex hormone levels between patients with migraine, patients with endometriosis, patients with migraine and endometriosis, and healthy controls. Participants will complete surveys, experimental pain paradigms and collection of samples for hormone analyses.
Primary Outcome
This psychophysical test examine the inhibitory pain modulation efficiency. In this test, pressure pain thresholds (measures by kilopascal) are assessed before and during immersion of the foot in cold water.
Conditions Studied
Interventions
- DEVICE Pressure stimuli
- BEHAVIORAL Pain ratings
- DEVICE Thermal stimuli
- BEHAVIORAL Conditioned pain modulation (CPM) response
- BIOLOGICAL Hormonal assessment
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-02-12 |
| Est. Completion | 2030-01-01 |
What NCT06785129 shows while recruiting
NCT06785129 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 357-participant average among 102 other Migraine trials with a reported enrollment target (66% lower).
The record links to 2 conditions, with Migraine appearing as the primary indexed condition, and to 5 interventions - of which Pressure stimuli is the first listed.
NCT06785129 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT06785129 about?
NCT06785129 is a clinical study titled "Endometriosis and Migraine". This study aims to determine differences in experimental pain and sex hormone levels between patients with migraine, patients with endometriosis, patients with migraine and endometriosis, and healthy controls. Participants will complete surveys, experimental pain paradigms and collection of samples ...
What is the current status of trial NCT06785129?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2025-02-12. Estimated completion is 2030-01-01.
What conditions does trial NCT06785129 study?
This clinical trial studies the following conditions: Migraine, Endometriosis.
What interventions are being tested in trial NCT06785129?
The interventions under investigation include: Pressure stimuli (DEVICE), Pain ratings (BEHAVIORAL), Thermal stimuli (DEVICE), Conditioned pain modulation (CPM) response (BEHAVIORAL), Hormonal assessment (BIOLOGICAL).
Who is sponsoring clinical trial NCT06785129?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06785129 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Migraine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06785129's enrollment target sits among peer trials
120 53rd of 102 higher than 49 of 102 other Migraine trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Migraine trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Migraine Manager (R01)
RECRUITING · Phase 2
-
MMA Embolization for Refractory Chronic Migraine
RECRUITING · NA
-
Stimulation of External Carotid Artery Circulation
RECRUITING · NA
-
Efficacy of Xeomin for Migraines in Patients With Traumatic Brain Injuries vs. Anomalous Health Incidents
RECRUITING
-
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
RECRUITING · Phase 3
-
Mechanistic Studies of Psilocybin in Headache Disorders
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI